A Motivation To Move

More individuals are finding they are more comfortable using an electric “scooter” when visiting a store or moving around outdoors. While there was a time when many only looked at this prospect as something that might make senior years easier the truth is it has been drafted for use by a steadily growing number of younger individuals.

A Motivation To Move: If it seems there is a more frequent use of electric mobility units by younger people there is a reason for that. It’s true.

More individuals are finding they are more comfortable using an electric “scooter” when visiting a store or moving around outdoors. While there was a time when many only looked at this prospect as something that might make senior years easier the truth is it has been drafted for use by a steadily growing number of younger individuals.

In order that you don’t see this as an overly alarming trend you should know that the use of physical mobility units is around 2% for those 50-64 years of age. As you can see the majority of those in this age group are not experiencing significant issues, but the secondary trend is that mobility is more difficult for those who don’t use a ‘scooter’. Many in this age group that can walk on their own indicate that climbing 10 stairs may be the maximum they can walk before needing to rest or walking more than ¼ of a mile is extremely difficult.

According to the Los Angeles Times, “More than 40% of people surveyed said that due to a health problem they had trouble with at least one of nine physical functions, without using any equipment. The researchers, from the University of Michigan and the RAND Corporation, also saw an increase in people needing help with personal care endeavors such as getting in and out of bed or moving around in their homes.”

Perhaps just as telling was the following information from the same article, “From 2005 to 2007, the most common reasons for needing help were arthritis; rheumatism; back or neck problems; diabetes; and depression, anxiety or emotional problems. Those who reported these problems were more apt to say the disorders started at age 30 to 49. Obesity was tied for seventh place on the list, tied with heart problems, and there was no substantial increase over the study period. In the study the researchers noted that some of the participants may not have wanted to list obesity, and that many obese people are healthy. Still, they wrote, ‘our findings regarding arthritis or rheumatism, back or neck problems, other musculoskeletal conditions, and diabetes may be related to the growth in obesity.’”

This trend seems to point to the potential that more direct health care will be needed at younger ages for many baby boomers. As the prevalence of obesity and diabetes continue to grow the issue of long-term and assisted care plays strongly in the potential of many American lives.

We Americans are reluctant to view ourselves as obese, but these trends point to the fact that too many calories are affecting not only our present, but also our future and the lives of those who love us.

One reality television show is pitching the idea of a revolution in how we think of food. This potential revolution advocated by Jamie Oliver suggests that something as simple as learning how to cook at home again instead of eating out so much could do more to stem the tide of obesity than anything.

Recent episodes of his reality television show demonstrate special caskets made for obese individuals along with the requirement that individuals who are excessively overweight may be required to purchase two burial plots to compensate for the size of the casket.

Startling images to be sure, but as the need for mobility devices increase so does the need for motivation to do something about these struggles common to all men.

The Importance of Friendships in Diabetic Care

What if I told you that in order to be successful in the managed care of diabetes you might need improved skills in interpersonal relationships? One study says I’m right.

The Importance of Friendships in Diabetic Care: What if I told you that in order to be successful in the managed care of diabetes you might need improved skills in interpersonal relationships? One study says I’m right.

Belinda (not her real name) lives in the Midwest. She is fearful of others and finds it hard to trust. Belinda is obese and developed both diabetes and asthma in her early 40s. She has been known to tell family members that she wishes she would just move far away from everyone and just be left alone. She won’t speak to some family members except via text or emails.

Belinda struggles with depression, which is common in those who have diabetes. She doesn’t have a positive body image and she finds it a struggle to just get up and venture out of her house. Her health continues to decline.

I mentioned a study in the opening paragraph of this story. According to PrivateMD, Paul Ciechanowski, associate professor of psychiatry and behavioral sciences at the University of Washington, and his colleagues examined 3,535 adult patients with type 1 and type 2 diabetes and had them fill out questionnaires regarding their personality and lifestyle.

”Participants were then divided into two groups – those with an independent style, who tended to be either dismissive or fearful of close relationships, and those with an interactive style, who generally felt comfortable seeking out support.”

You might expect that there would be some problems with those who find themselves fearful of interaction with others, but the truth might surprise you, “Over the duration of the study, individuals who were more introverted and mistrustful had a 33 percent higher mortality rate than those who were more extraverted and emotionally open. The mortality rates remained the same after accounting for potential risk factors, such as age, body mass index and other medical conditions.”

With the advent of modern technology it is possible for an individual to develop a dependence on personal communication devices inside their home in order to physically remove themselves from other people. Like Belinda many push family members and friends away because they erroneously believe no one wants to be around them in the state in which they find themselves.

Managing diabetes can be a collaborative effort between yourself and someone who cares about you. When you leash yourself to an electronic tether that makes no demands with respect to connecting with others on a face-to-face basis you can find comfort on one level, yet a profound separation on another.

This is another example of psychological component that plays a key role in the outlook and personal care an individual will perceive as acceptable. In other words for someone like Belinda who struggles with trust there may be an acceptance of care and comfort that is less comprehensive than others who work at developing a support network.

The Internet has provided a great resource in finding information and connecting with others in a casual manner, but the Internet cannot hold your hand, dry your tears or provide the personal encouragement a flesh and bone friend can.

By intentionally working on interpersonal relationships as part of your diabetic care you may find that there are greater moments of joy and less bouts of loneliness and depression than by insisting you are strong enough to do this thing called diabetes alone.

Diabetes and the Oxygen Deprived Mouse

Certain oxygen-deprived mice seem to thrive by eating as much as they want, staying lean in the process and avoiding any diabetic symptoms. What scientists learn from these mice may aid in future diabetic care.

Diabetes and the Oxygen Deprived Mouse: Certain oxygen-deprived mice seem to thrive by eating as much as they want, staying lean in the process and avoiding any diabetic symptoms. What scientists learn from these mice may aid in future diabetic care.

According to a press release on the subject these mice, “process fat differently,” said Randall Johnson, professor of biology at the University of California, San Diego, who directed the research, which is published in the April 15 issue of the journal Cell Metabolism. While their normal littermates gain weight, develop fatty livers and become resistant to insulin on a high fat diet, just like overweight humans do, the mutant mice suffered none of these ill effects.”

This report cites a protein called FIH that dictates the response a body has in low oxygen level conditions. The authors of the study indicate drugs can inhibit the protein. The press release stated, “Because the protein influences a wide range of genes involved in development, the scientists were surprised that its deletion improved health.”

“We expected them to die as embryos,” said Na Zhang, a graduate student in Johnson’s lab and lead author of the study. “Then we saw they can survive for a long time.”

“From the beginning I noticed that these mice are smaller, but not sick. These mice seem to be healthy,” Zhang said. The lean mice have a high metabolism, and a common check for insulin resistance, a symptom of diabetes, revealed a super sensitivity to insulin.

“We fed the mice with a very high fat diet – 60 percent fat – just to see how they would respond,” Zhang said. “Mutants can eat a lot, but they didn’t gain a lot of weight. They are less fatty around their middles compared with their littermates.”

In reference to the comparison between the oxygen deprived mutant mice and humans the theory seems to be that with the inhibition of FIH cholesterol levels go down, instances of fatty liver decline and metabolic profiles improve.

Researchers noted that these FIH deprived mice ate more and drank more than mice without the protein deficiency, but according to Johnson the calories went, “To heat generation and an increased heart rate. They also breathe heavily compared with normal mice, taking in 20 to 40% more air. This deep breathing is like exercise for them.”

The protein deficiency was replicated in other mice and found to provide the same response. However, the FIH has to be deprived in virtually all tissue in order to be successful. It was tried in the liver only with limited results.

The press release concludes by saying, “The FIH protein is part of a wide system that responds to low levels of oxygen. The mice behave as if they are breathing thin air. When people travel to higher altitudes, they breathe heavily for a few days, then adjust by producing more oxygen-carrying blood cells. ‘These mice never adjust to the apparent low oxygen,’ Johnson said. ‘They stay in this acute phase of hypoxic response their whole lives.’”

In essence the oxygen deprivation requires more active work to gain the needed oxygen allowing the metabolism to kick into overdrive as the mice develop faster heart rates and quicker breathing techniques. The end result is a greater need for fuel, but a reduced risk for diabetes.

I don’t believe the researchers are suggesting that we cure diabetes by making patients oxygen deprived, but there may be some elements of the research that can assist in the development of new therapies to aid in the struggle against diabetes.

The World of Team Type 1

The world of cycling is being impacted by Type 1 diabetes. In fact one team is hoping their efforts results in a run at the Tour de France in 2012.

The World of Team Type 1: The world of cycling is being impacted by Type 1 diabetes. In fact one team is hoping their efforts results in a run at the Tour de France in 2012.

There are six teams that make up Team Type 1. These include professional men and women’s teams, a triathlon team and a development team. According to the Team Type 1 website, “Team Type 1 is the world’s only professional cycling team with a roster that includes riders who have Type 1 diabetes.

“In 2009, Team Type 1 won 55 races, finished fourth in the National Racing Calendar (NRC) standings and captured the King of the Mountains title at five races, including the Tour of Missouri. In two seasons, the squad has registered 100 victories and 219 podium (top three) finishes.

“Four of the 17 riders have Type 1 diabetes: Fabio Calabria, Joe Eldridge, Javier Megias and Martijn Verschoor. In addition to nine Americans, there are riders from Australia, Holland, Italy, Russia, Slovenia, Spain and the Ukraine.”

As Team Type 1 has grown they’ve also assembled a cycling team featuring those who live with Type 2 diabetes. The emphasis has been to educate others on ways to combat diabetes while still pursuing the dreams each person has for their lives. This has included multiple placings in national and international cycling events.

It was also recently announced via press release, “Team Type 1 and 23andMe announce a strategic partnership to research and understand Type 1 and Type 2 diabetes through 23andMe’s Personal Genome Service. 23andMe, an industry leader in personal genetics, conducted a genetic analysis of all 88 members of Team Type 1, to investigate diabetes and how genes impact athletic performance. The analysis was conducted at Team Type 1’s training camp in Georgia where saliva samples from each team member were collected.

“The process by which 23andMe genotypes DNA uses the latest in DNA technology. Once the lab receives a sample of a person’s saliva, DNA is extracted, cut into smaller, more manageable pieces and applied to a DNA “chip.” The DNA chip is a small glass slide with millions of microscopic beads on its surface. Attached to each bead are “probes”—bits of DNA complementary to sites in a person’s genome where their single nucleotide polymorphisms, or SNPs, are located. SNPs act as biological markers and allow scientists to locate genes associated with disease.”

This partnership between Team Type 1 cyclists and the 23andMe follows other successful partnerships with the NFL in determining how athletics affects the human body.

Team Type 1 is also using social media like Twitter and Facebook to connect with their fans and provide updates on pending races and weekly success stories.

Phil Southerland is the brainchild behind Team Type 1. According to his personal website he, “was diagnosed with Type 1 diabetes at 7 months of age. He lived in Tallahassee, Florida. He was born and diagnosed at Tallahassee Regional Medical Center. Phil’s mother, Joanna, kept taking him to doctors for a week saying something was wrong. He was finally diagnosed after she took him to the ER on her own. The lives as a family changed that instant. At that time she was told good news “He will live.” Bad news, “He has juvenile diabetes and the prognosis that he would probably have renal failure or be blind by age 25. Instead, at 24 years of age he raced his bike 3000 miles across the United States with a team of other persons with Type 1.”

To find out more about the efforts of Team Type 1 visit teamtype1.org.

The Big News in Protein Study Funding for Diabetes

One research institute has received more than a million dollars to fund a series of tests designed to study a protein linked to the development of obesity and diabetes. The three years of research will take place in Florida.

The Big News in Protein Study Funding for Diabetes: One research institute has received more than a million dollars to fund a series of tests designed to study a protein linked to the development of obesity and diabetes. The three years of research will take place in Florida.

Patricia McDonald, an associate scientific director in the Translational Research Institute at Scripps Florida was quoted in a press release following word of the $1.3 million in funding, “Because obesity and diabetes are two of the most serious health problems facing us, the need for novel treatments has never been greater,” McDonald said. “Some recent studies in animal models have shown that activating the G protein-coupled receptor GPR119 improves glucose homeostasis or balance, while positively affecting both food intake and weight gain. This funding will help us design new assays that will explore the overall potential of GPR119 – and may one day lead to more effective treatments.”

The press release continued, “G protein-coupled receptors (GPCRs) are the largest and most diverse protein family in the human genome. They transduce or convert extracellular stimuli including neurotransmitters, light, hormones, lipids, and peptides into intracellular signals through a number of signaling pathways. Approximately one third, and perhaps as many as half, of currently marketed drugs are designed to target these receptors.

“GPR119 is expressed predominantly in the pancreas and gut of humans and rodents and in the rat brain. When activated, the receptor promotes secretion of a specific hormone, called Glucagon-Like Peptide-1 (GLP-1), in the intestines, which in turn increases insulin secretion from the pancreas; both are key components in regulating the balance of glucose in the body. Although some modulators of GPR119 have been discovered, they do not necessarily mimic the receptor’s natural ligand and have thus turned out to be mostly unsuitable for use in studying the receptor’s biology and function.”

One of the most fascinating, and science altering discoveries in our most recent past is the human genome project. This information will be used in the new Scripps research, “With the human genome sequenced, science now has a good handle on just how many GPCRs exist – at least 1,000 or more. Of those, McDonald said, scientists have a good understanding of what approximately 200 of them actually do and what activates them; another 600 or so are involved in taste and smell. The remaining receptors are known as orphan receptors, whose function and natural ligands have yet to be discovered,” according to the release.

McDonald said, “This funding is so important to eventually find[ing] more effective treatments for diabetes and obesity.”

The crucial funding provided to Scripps Research will be used to follow several potential scenarios in which these body proteins can be used to help individuals manage their weight as well as diabetic risk.

The press release describes Scripps Research as, “One of the world’s largest independent, non-profit biomedical research organizations, at the forefront of basic biomedical science that seeks to comprehend the most fundamental processes of life. Scripps Research is internationally recognized for its discoveries in immunology, molecular and cellular biology, chemistry, neurosciences, autoimmune, cardiovascular, and infectious diseases, and synthetic vaccine development. Established in its current configuration in 1961, it employs approximately 3,000 scientists, postdoctoral fellows, scientific and other technicians.”

Their collective brain trust will be called upon to learn what they can from G-protein as relates to the effective management of weight and diabetic control.

A Diabetic Defense for Technology

There is a standard phrase that iPhone users often say; “There’s an app for that.” When choosing low calorie meals some are arming themselves with an app for mealtimes on the go.

A Diabetic Defense for Technology: There is a standard phrase that iPhone users often say; “There’s an app for that.” When choosing low calorie meals some are arming themselves with an app for mealtimes on the go.

Alyssa is not diabetic, but other family members have developed the disease. Her dad bought her an iPod iTouch for Christmas and like most teens she uses it to play games, connect to the Internet in Wi-Fi hotzones, listen to music, watch videos and post to Facebook. However, she’s also discovered key application downloads that fills her in on nutritional information about restaurants she visits.

The movie “Super Size Me” had a big impact on Alyssa and she wants to be smart on those increasingly rare occasions when she does eat out. Now while she waits in line she manipulates her iTouch screen and locates the data. She is surprised to see that some of the salads she thought were healthy actually have more calories than a burger once the dressing and tasty add ons are factored in.

She is surprised by the calories associated with some of the fries she has taken for granted and there are some items that she now totally avoids, “I remember looking up one burger special and found it was something like 1,100 calories – without the fries and drink.”

The good news is Alyssa doesn’t like pop so she doesn’t have a huge worry about sugar adding to any potential obesity problem.

“There are some places I just won’t go anymore,” said the 15 year-old, “Some food items I just can’t eat now that I know more about them.”

Has she noticed any changes in her family?

“My dad is always asking me to look stuff up when we eat out. He changes his mind about food all the time because of what my iTouch says.” Alyssa smiles. “We eat at home a lot more now.”

Alyssa’s mom, Nancy, has also noticed a difference; “I love the fact that Alyssa is taking ownership in her decisions. She’s recognizing at an early age that what she does today can affect her future. Now if only I could convince her brother it’s important.”

This is just one true story of how mobile technology is empowering people to make better choices. For the diabetic, mobile technology can allow you to monitor your glucose levels, make digital notes and even send data to an off-site tracking location. Some diabetics will even forward their data to their primary care physician for input when needed.

As more and more people accept the use of mobile technology they may find these devices can place vital information at their fingertips in between all of the games, music, emails and Facebook posts.

These devices have also made it possible for many diabetics to assume a greater level of freedom simply because they are no longer tied to bulky testing equipment and data storage issues.

“My grandma died from diabetes a couple of year ago,” Alyssa says as she looks at a picture of her grandmother from 2005 on her iTouch. “Every day she inspires me to make better choices. I know that sounds weird, but somehow it helps.”

Alyssa has two aunts with diabetes and although she is young and looks the picture of health Alyssa realizes the choices she makes today can impact her future. If you ever meet Alyssa in a restaurant you might ask her what she might recommend. You can bet the portions will be sensible and the food low in fat, sodium and calories. Oh, and she’ll be using a hand-held iTouch to pass along her wisdom.

Introducing Rock For Diabetes

A relatively new organization enlists the aid of musicians (past and present) who were diagnosed with diabetes in an effort to affect change in habits and attitudes about the disease primarily among those who are young.

Introducing Rock For Diabetes: A relatively new organization enlists the aid of musicians (past and present) who were diagnosed with diabetes in an effort to affect change in habits and attitudes about the disease primarily among those who are young.

The organization is known as RockForDiabetes.org, which was started by Brian Medek, who in 1983 at the age of four was diagnosed with Type 1 diabetes.  Today the organization works with bands like the Jonas Brothers to help spread awareness of the organization as well as the disease. This isn’t especially difficult since Nick Jonas lives with the disease and has provided solid backing for the organization’s efforts. The organization hopes that support groups can be developed along with camping programs and fundraisers.

The Jonas brothers have committed to at least one fundraiser in connection with Rock For Diabetes. The site provides band interviews for listeners, which serves as a huge draw that then enables visitors to receive the information they may need in dealing with the potential of diabetes. One comment posted prominently on the site suggests, “If you take anything anyway from this, remember that 57 million Americans can avoid getting diabetes, if they just ate right with some mild exercise.”

The Rock For Diabetes site lists multiple prominent musicians who struggle(d) with diabetes.

– Nat Adderley – Jazz Musician
– Syd Barret – Singer (Pink Floyd)
– Danny Joe Brown – Singer (Molly Hatchet)
– James Brown – ‘The Godfather of Soul’
– Johnny Cash – ‘The Man in Black’
– Mark Collie – Country Singer
– David Crosby – Singer (Crosby, Stills, and Nash)
– Miles Davis – Jazz Musician
– Johnny Darrell – Country music singer
– Phife Dawg – Rapper (A Tribe Called Quest)
– Mama Cass Elliott – Singer (Mamas and the Papas)
– Ella Fitzgerald – Singer
– Mick Fleetwood – Musician (Fleetwood Mac)
– Aretha Franklin – ‘The Queen of Soul’
– Melvin Franklin – Singer
– Jerry Garcia – Singer, Musician (Grateful Dead)
– Dizzy Gillespie – Jazz Musician
– Shirley Horn – Grammy-winning Jazz singer and pianist
– Marvin Isley – Singer (The Isley Brothers
– Mahalia Jackson – Gospel Singer
– Rick James – Singer (“Super Freak” Funk Legend)
– Waylon Jennings – Country Singer
– Herbert Kahury (“Tiny Tim”) – Singer
– B.B. King – Blues Singer and Musician
– Patty LaBelle – Soul singer
– Peggy Lee – Jazz singer, Grammy winner
– Tommy Lee – Drummer (Motley Crue)
– Curtis Mayfield – Soul singer
– Bret Michaels – Singer (Poison)
– Elvis Presley – Singer and guitarist
– Jessica Stone – Singer and Actress
– Neil Young – Singer and guitarist
– Gary Valenciano – Philipinno singer
– Luther Vandross – Singer
– Norman Whitfield – Grammy winning R&B songwriter and record producer
– Nick Jonas – Singer and Guitarist (the Jonas Brothers)
– Elliot Yamin – Singer
(Source: RockForDiabates.com)

The main thrust of this organization is to work at gaining the attention of young people when there may be time to change habits before a doctor insists a change is necessary. If young people can be reached in such a cutting edge way then it may be possible to alter the destiny of some who might potentially become diabetics.

Adding the ‘cool factor’ resource of bands, branded clothing and a completely modern presentation might serve to allow young individuals more opportunity to consider the message.

Diabetic Care Takes a Road Less Traveled

What does a company that provides financial tools and online auctions to countries outside the U.S. have to do with diabetic testing supplies? Well, if your company “invests in technologies, communities and systems that facilitate trade, finance, communication and travel across international boundaries, cultures and languages” then you might be surprised what you can do for diabetics.

Diabetic Care Takes a Road Less Traveled: What does a company that provides financial tools and online auctions to countries outside the U.S. have to do with diabetic testing supplies? Well, if your company “invests in technologies, communities and systems that facilitate trade, finance, communication and travel across international boundaries, cultures and languages” then you might be surprised what you can do for diabetics.

The company is known as One World Ventures, and a lengthy process of approvals for a subsidiary is finally allowing them to move beyond travel and financial tools to the world of diabetic testing supplies.

According to a press release issued recently One World Venture’s “manufacturing subsidiary Tutamen has applied for and received approval for exclusive distribution of the Eukare(R) blood glucose monitoring system in Mexico. The application for importation of the system was made with Mexico’s Federal Commission for Protection Against Health Risks (COFEPRIS) and has been approved by the Mexican Secretariat of Health. The system is a critical part of the ongoing battle against Type II diabetes which has reached epidemic levels in Mexico. The Eukare(R) system is Food and Drug Administration (FDA) approved in the U.S. and ISO and CE compliant.”

The company anticipates that its established presence in Mexico, Central America and Africa could provide ample reason to succeed in places that are not well serviced. Company officials fully expect to see in excess of $2 million in first year sales.

The release further suggests, “With this approval, One World will create a medical devices division of the company that will focus on the manufacturing and delivery of medical devices to areas where there is opportunity to provide for the underserved. Presently, the major pharmaceutical conglomerates with a much higher cost structure are the primary providers of diabetes testing supplies in Mexico.”

Mexican officials indicate diabetes will be diagnosed in 40% more cases by 2012 leaving a significant need for testing supplies for personally managed care.

One World CEO Steve Prior said, “The Eukare System allows us to distribute a quality medical device in a more cost effective manner to people who desperately need the care. It has been an arduous process getting these approvals. We anticipate shipping into Mexico very soon now that we are complete.”

Tutamen, the subsidiary of One World that is manufacturing the blood glucose monitors is based in China. One World website data indicates, “Tutamen was a startup company established in Shenzhen China in 2003. Since that date Tutamen (HK) Ltd has established itself with a core of consistent clients managed by Tutamen (HK) Ltd. The Company has also established excellent technical and manufacturing partners throughout the region. Tutamen provides comprehensive consulting services to help companies achieve rapid, sustained success in China and the US.”

Time will tell if this new venture proves a success. It does appear that the company may have the connections needed to allow for the benefit of diabetics in less populated areas of Mexico and the business model may prove strong enough to allow growth into other worldwide markets. It is also possible that the growth of One World Ventures could encourage other manufactures to develop a larger distribution base in order to successfully compete.

In either case this development provides both short term as well as long term hope that managed care in diabetes can become more available on a global scale.

Revisiting Diabetic Supply Availability

With so many changes taking place in the arena of health care it can be difficult to keep up. However, one change is already under consideration for revision. One provision for Medicaid would need to be changed in order to protect underserved members of America’s rural heritage.

Revisiting Diabetic Supply Availability: With so many changes taking place in the arena of health care it can be difficult to keep up. However, one change is already under consideration for revision. One provision for Medicaid would need to be changed in order to protect underserved members of America’s rural heritage.

Betty lives in Iowa in a small town several miles from a chain pharmacy. She has always relied on the independent small town pharmacist to help her manage her medications. In fact, Betty and the pharmacist go to the same church, but certain provisions in how diabetic medical supplies are bid would make it virtually impossible for the small town pharmacist to continue to provide the supplies. Essentially Betty will have to travel 35 miles one way to buy her supplies.

This same story could be true in places like Alaska, Kansas, Arkansas, Texas, New Mexico, Wyoming, Montana and the state list just gets longer and longer.

A bill designed to provide the greatest savings may not have taken into account the real needs of all diabetic patients. According to DrugStoreNews.com two lawmakers are determined to do something about it. “Reps. Peter Welch, D-Vt., and Mike Rogers, R-Mich, have introduced the Medicare Access to Diabetes Supplies Act, a bill that exempts small pharmacies from the Centers for Medicare and Medicaid Services’ final competitive bidding program for Medicare Part B durable medical equipment, prosthetics, orthotics and supplies.”

The struggle for small pharmacists is they do not have enough business to offer the sharp discounts a larger retail pharmacist can. If they could offer the same prices they would likely lose money on each sale. Since they don’t have the same buying power as larger retail counterparts they remain at a distinct disadvantage in how a price can be assigned by Medicaid services. The article from Drug Store News continues, “Small community pharmacies — currently classified by the Small Business Administration’s definition as having annual sales of $7 million dollars or less — would be able to maintain the pharmacist-senior patient relationship if this bill becomes law, since it would keep healthcare options for seniors who use DMEPOS, particularly those patients living in underserved areas.”

In a small community pharmacy in Kansas, Angie has been helping her neighbors understand drug interactions and drug benefits for years, yet she is faced with the disturbing possibility that her patrons may be required to use mail order or travel in order to get the same information and prescriptions from a larger and less familiar source. Bruce Roberts, NCPA (National Community Pharmacists Association) EVP and CEO agrees, “This legislation allows seniors to continue obtaining essential medical supplies like diabetes testing strips from their local community pharmacy. The current competitive bidding program favors larger healthcare providers at the expense of smaller ones like community pharmacies. As a result many seniors who get these supplies from community pharmacies could be forced to travel many miles or go through mail order without the face-to-face consultation that helps maximize health outcomes.”

If Welch and Rogers are successful in their Medicare Access to Diabetes Supplies Act it will likely mean a greater comfort level in the way diabetic supplies are acquired by those on Medicare and Medicaid. While we don’t supply a political call to action you are certainly welcome to contact your representative and let him or her know how you feel about the availability of diabetic supplies to all Americans.

Joslin Clinic

The Joslin Diabetes Center is part of the Joslin Clinic. The clinic was one of the first and most respected diabetes care centers in the world. They have spent billions of dollars on diabetes research The Joslin Diabetes Center is the only center in the world that has multiple focuses. They research diabetes causes and more treatments, they care for countless patients and they educate families on diabetes.

Joslin Clinic: The Joslin Diabetes Center is part of the Joslin Clinic. The clinic was one of the first and most respected diabetes care centers in the world. They have spent billions of dollars on diabetes research The Joslin Diabetes Center is the only center in the world that has multiple focuses. They research diabetes causes and more treatments, they care for countless patients and they educate families on diabetes.

Joplin’s research team is dedicated solely to diabetes all over to word. They have more than 300 scientists at Joslin that are looking for ways to prevent, treat and cure both types of diabetes and the complications that come with them. Already they have taken steps to improve diabetes care throughout the world. They have recognized that tight blood glucose control can slow and even prevent diabetes complications. They have created treatments so that women who have diabetes can go to have safe pregnancies and deliver healthy babies. They have also managed to bring out laser surgery for diabetic eye disease. Joslin has been awarded recognition from some of the top diabetes associations such as the American Diabetes Association, and the Juvenile Diabetes Research Foundation.

Joslin Clinic is the home of a program called JoslinCare. This program promotes lifelong health in those who have diabetes through medical care, patient education and the prevention and the management of complications. JoslinCare’s team is experts in all parts of diabetes including adult and pediatric diabetes. They can also help educate diabetics and their families on kidney disease, eye care, and mental issues and even help those who are pregnant. JoslinCare also offers support for kids and their families. They deal with children of all ages, from very young children and school age children to teens. This is a one of a kind program that is no where else.

Lastly Joslin Clinic host to the Joslin’s Strategic Initiatives Division. This division was created in 1998 and it focuses on improving the quality of diabetes care around the world by educating people. They offer Joslin’s professional education programs that reach nearly 35,000 physicians and other professionals every year. This program helps healthcare providers set a better standard of diabetes care for their communities. The Joslin’s Disease Management Program is just that. If offers tools to people to help reduce short and long term complications and increase the quality of life in a diabetic. It helps reduce patient times in hospitals and helps reduce lost time from work. This program reaches more physicians al over the world than any other one. Educating health care professionals and educating diabetics is the most important thing to the Joslin clinic.

Perhaps one of the best things about Joslin is that they work with your primary care physician. The team of experts that you work with through Joslin will be in touch with your physician to help you manage your diabetes. You will be going to appointments at Joslin, but in-between you will still see your doctor to keep your diabetes under control. Joslin works with every aspect of your life to help make sure that you live a long and comfortable, complications free life.

Secret Link